Heptitis C Drug Therapies - Long Term Fiscal Impact to Medicae Program

This is a Request for Quotation prepared in accordance with FAR Part 13, as supplemented with additional information included with this notice. THIS ANNOUNCEMENT CONSTITUTES THE ONLY SOLICITATION; A SEPARATE WRITTEN SOLICITATION WILL NOT BE ISSUED. QUOTES ARE BEING REQUESTED. The Centers for Medicare and Medicaid Services intends to award using Simplified Acquisition Procedures, a fixed priced purchase order at a fixed price to purchase for "Evaluation of Long-Term Fiscal Impact to the Medicare Program of Recently Developed Hepatitis C Drug Therapies" in accordance with the attached Statement of Work, Statement of Deliverables, Technical Criteria."All business proposals final price shall be submitted in whole dollars only, rounded to the nearest dollar." The North American Industry Classification Code (NAICS) is 541990. The Request for Quote (RFQ) is being set aside for small business concerns. Responses must be sent electronically in MS Word format to renee.wallaceabney@cms.hhs.gov on or before August 9, 2018 by 2:00 pm EST to Renee Wallace-Abney, The Government intends to award an order to the responsible offeror whose quotation offers the best combination of technical capabilities and proposed price; the best value (considering price and other factors). All responses/quotes submitted shall remain valid for a period of 180 days. Interested parties must be able to affirm no conflicts of interest with parties involved in Medicare claims processing in light of the work identified in this Statement of Work. In the event that the vendor/government identifies a conflict, the vendor shall be responsible for providing a mitigation strategy that satisfies the government. In the event that the conflict cannot be resolved, the order cannot be awarded or an existing order may need to be terminated..